로딩 중…
지수 로딩 중…
JS Link
127120· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩35,900+1.99%
2026-06-19
Price Chart
JS Link+287.69%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 1.24T KRW |
| Revenue | 20.31B KRW |
| Net Income | -15.76B KRW |
| Total Assets | 143.32B KRW |
| Net Assets | 89.37B KRW |
| Employees | 80 |
| Value | |
| P/B | 13.91x |
| P/S | 61.21x |
| FCF Yield | -4.30% |
| Profitability | |
| ROE | -17.64% |
| ROA | -11.00% |
| Op. Margin | -61.98% |
| Revenue Growth | 69.40% |
| Financial Health | |
| Debt Ratio | 160.37% |
| Total Debt | 34.07B KRW |
| FCF | -53.44B KRW |
| Cash | 59.05B KRW |
| Current Ratio | 1.72x |
| Performance | |
| 1Y Return | 287.69% |
| 1M Return | -1.78% |
| From 52W High | -28.06% |
| 1Y MDD | -36.81% |
| Trading | |
| Volume | 133,095 shares |
| Foreign Own. | 2.19% |
| Per Share | |
| EPS | -525 KRW |
| BPS | 2,591 KRW |
Company Info
Established in 2000 as a personalized medicine specialized healthcare company, the company will change its name to JS Link in 2025. It operates genome analysis technology-based services and molecular diagnostics businesses. Through an amendment to its articles of incorporation, JS Link is expanding into the production of permanent sintered magnets for future industries like electric vehicles and robots. The company is preparing for manufacturing by securing rare earth procurement partnerships, talent, and facility investments, while pursuing innovation in its technology platform. JS Link is headquartered in Gangseo-gu, Seoul Metropolitan City.